RecruitingNCT04939922

China Headache and Vertigo Registry Study

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

10,000 participants

Start Date

Jun 12, 2017

Study Type

OBSERVATIONAL

Conditions

Tension-type headache Fibromyalgia Migraine Cluster Headache Headache Disorders, Primary Headache Disorders, Secondary Vertigo, Constant Vestibular Migraine

Summary

In the Chinese Headache and Vertigo Registration Study, patients aged 4-99 years with headache (primary headache and secondary headache such as migraine and tension type headache), vertigo (vertigo diseases such as vestibular migraine) and chronic pain (fibromyalgia and other diseases) were collected. The biomarkers, imaging features, right-to-left shunt of the heart (lung), genetic characteristics, treatment, and outcome (in relation to other diseases) of headache-related diseases were studied, and long-term follow-up was planned.

Eligibility

Min Age: 4 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cluster headache, fibromyalgia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 4 Years to 99 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.